NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/11/2026
Back to search
Official data from USPTO
SANDOSTATIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
08/11/2026
Trademark type
Word
Nice classes
5
Filing date
12/09/1985
Registration date
10/14/1986
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/11/2026
Last transaction
08/11/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
10/23/1985
First use in commerce
10/23/1985
Drawing code
1
Owner type
03
Owner location
Basel, CH
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Novartis AG
S. C. (pessoa física)
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
MEDICINAL PREPARATION USEFUL IN THE MANAGEMENT OF GASTROINTESTINAL ENDOCRINE TUMORS
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
08/11/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/11/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/11/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
06/15/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/14/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/06/2016
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
10/06/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/06/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/06/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
07/25/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/14/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/19/2009
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/14/2006
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/14/2006
PLGL
ASSIGNED TO PARALEGAL
10/03/2006
CFIT
CASE FILE IN TICRS
09/29/2006
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
07/17/2006
E89R
TEAS SECTION 8 & 9 RECEIVED
07/17/2006
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/19/2004
PAPER RECEIVED
12/06/2004
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/02/1992
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
06/30/1992
R.PR
REGISTERED-PRINCIPAL REGISTER
10/14/1986
PUBO
PUBLISHED FOR OPPOSITION
07/22/1986
NPUB
NOTICE OF PUBLICATION
06/22/1986
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/1986
ZZZZ
ALLOWANCE/COUNT WITHDRAWN
03/28/1986
DOCK
ASSIGNED TO EXAMINER
03/20/1986
Continuous trademark protection
Get notified about every new filing that threatens SANDOSTATIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.